Semaglutide is the active ingredient behind well-known medications like Ozempic, Wegovy, and Rybelsus, approved for treating type 2 diabetes and helping with significant weight loss
Tools for treating obesity
This can lead to weight cycling, which has been shown to cause fluctuations in cardiovascular risk factors, such as blood pressure, heart rate, sympathetic activity, and circulating levels of glucose, lipids and insulin
Upon binding to GLP-1 receptors on pancreatic beta cells, these agents stimulate glucose-dependent insulin secretion via increased cyclic AMP (cAMP) production and subsequent calcium influx
38 Oral Route of Semaglutide The degradation of peptide-based drugs by proteolytic enzymes, the low permeability of intestinal epithelium and its mucus layer and the low pH of the gastrointestinal tract, are the major barriers preventing the oral administration of GLP-1RAs
The medical approach helped me lose weight in a way that feels manageable and realistic